July 20th, 2023
CanBiocin Receives Patent for its Innovative Wolf-Derived Probiotic for Dogs.
CanBiocin’s Probiotic Bacteria Isolated from Wolves and Related Compositions and Methods is a pioneering product that aims to enhance the overall health and well-being of canine companions by promoting a balanced and robust gut microbiome.
March 15th, 2023
CanBiocin Granted Sole License for Patented Microencapsulation Technology.
Microencapsulation patented process instrumental for protecting heat sensitive bioactive materials.
Edmonton AM with Mark Connolly: April 11th, 2023
The University of Alberta's Health Innovation Hub is an incubator to help commercialize health and science discoveries at the university. CanBiocin is a company which develops probiotics for animals. The direction of the company was set during a brain storming session among the founders, all of whom were pet owners. CEO Jake Burlet, who is a veterinarian, explains how that discussion led to a new direction for the company.